Novo Nordisk
NVO
#120
Rank
โ‚น16.153 T
Marketcap
โ‚น3,659
Share price
-1.16%
Change (1 day)
-30.16%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.141 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.22 Billion. In 2025 the company made an earning of โ‚น2.028 Trillion, an increase over its 2024 earnings that were of โ‚น1.908 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.141 T5.56%
2025 โ‚น2.028 T6.28%
2024 โ‚น1.908 T28.01%
2023 โ‚น1.490 T57.81%
2022 โ‚น944.77 B5.24%
2021 โ‚น897.76 B12.38%
2020 โ‚น798.85 B13.11%
2019 โ‚น706.27 B-3.45%
2018 โ‚น731.50 B1.88%
2017 โ‚น717.98 B4.3%
2016 โ‚น688.36 B10.32%
2015 โ‚น623.95 B7.47%
2014 โ‚น580.60 B3.4%
2013 โ‚น561.50 B19.09%
2012 โ‚น471.51 B15.58%
2011 โ‚น407.96 B16.58%
2010 โ‚น349.94 B25.66%
2009 โ‚น278.49 B10.68%
2008 โ‚น251.63 B55.82%
2007 โ‚น161.49 B7.02%
2006 โ‚น150.89 B19.05%
2005 โ‚น126.74 B10.55%
2004 โ‚น114.64 B
2002 โ‚น77.28 B-14.39%
2001 โ‚น90.27 B-52.82%
2000 โ‚น191.32 B250%
1999 โ‚น54.66 B31.21%
1998 โ‚น41.66 B34.31%
1997 โ‚น31.01 B11.46%
1996 โ‚น27.82 B9.03%
1995 โ‚น25.52 B-3.15%
1994 โ‚น26.35 B-0.67%
1993 โ‚น26.52 B45.38%
1992 โ‚น18.24 B-13.81%
1991 โ‚น21.17 B37.12%
1990 โ‚น15.43 B-0.79%
1989 โ‚น15.56 B26.2%
1988 โ‚น12.33 B24.97%
1987 โ‚น9.86 B-0.9%
1986 โ‚น9.95 B-7.78%
1985 โ‚น10.79 B24.87%
1984 โ‚น8.64 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น668.39 B-70.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.251 T 44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น692.90 B-69.16%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น1.152 T-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA